Pennsylvania SR300 recognizes May 2026 as "Myositis Awareness Month" to highlight the impact of this rare autoimmune disease.
Pennsylvania SR300 designates May 2026 as "Myositis Awareness Month" to bring attention to this rare autoimmune disease that causes muscle inflammation and weakness. The resolution acknowledges the various forms of myositis, including juvenile myositis, dermatomyositis, polymyositis, and inclusion body myositis, which can affect internal organs, skin, and multiple muscle groups. It highlights the estimated 75,000 people in the U.S. affected by myositis and the treatments available, such as immunosuppressants, corticosteroids, and physical therapy.
Included in complete analysis
- Overview
- Core Provisions
- Implementation
- Impact
- Legal Framework
- Critical Issues
See what it does, who it affects, and the critical issues in plain language. Free, 30 seconds.